JPH0465049B2 - - Google Patents

Info

Publication number
JPH0465049B2
JPH0465049B2 JP56502536A JP50253681A JPH0465049B2 JP H0465049 B2 JPH0465049 B2 JP H0465049B2 JP 56502536 A JP56502536 A JP 56502536A JP 50253681 A JP50253681 A JP 50253681A JP H0465049 B2 JPH0465049 B2 JP H0465049B2
Authority
JP
Japan
Prior art keywords
tyrosine
brain
tryptophan
levels
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56502536A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58501117A (ja
Inventor
Richaado Jei Waatoman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1981/000963 external-priority patent/WO1982000250A1/en
Publication of JPS58501117A publication Critical patent/JPS58501117A/ja
Publication of JPH0465049B2 publication Critical patent/JPH0465049B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Apparatuses For Generation Of Mechanical Vibrations (AREA)
  • Micromachines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50253681A 1981-07-15 1981-07-15 正常なひと患者における精神賦活剤 Granted JPS58501117A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1981/000963 WO1982000250A1 (en) 1980-07-15 1981-07-15 Process for improving vigor and mood in normal human patients

Publications (2)

Publication Number Publication Date
JPS58501117A JPS58501117A (ja) 1983-07-14
JPH0465049B2 true JPH0465049B2 (enrdf_load_stackoverflow) 1992-10-16

Family

ID=22161322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50253681A Granted JPS58501117A (ja) 1981-07-15 1981-07-15 正常なひと患者における精神賦活剤

Country Status (1)

Country Link
JP (1) JPS58501117A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233136A1 (en) * 2006-08-18 2010-09-29 Syngenta Limited Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
GB1496254A (en) * 1975-07-28 1977-12-30 Ajinomoto Kk Nutritive infusion solution and its production
JPS5627493A (en) * 1979-08-14 1981-03-17 Nippon Electric Co Method and device for identifying bill

Also Published As

Publication number Publication date
JPS58501117A (ja) 1983-07-14

Similar Documents

Publication Publication Date Title
Birkmayer et al. Implications of combined treatment with'Madopar'and L-deprenil in Parkinson's disease: a long-term study
Kernbaum et al. Administration of levodopa for relief of herpes zoster pain
RU2140266C1 (ru) Фармацевтическая композиция с регулируемым выделением на основе одной или нескольких фармацевтически приемлемых солей гамма-гидроксимасляной кислоты и способ ее получения
AU606413B2 (en) A method and a composition for treating neurological diseases such as migraine, by influencing the nerve cells
DK174017B1 (da) Anvendelse af gamma-hydroxysmørsyresalte til fremstilling af farmaceutiske præparater til behandling af alkoholisme
Lindén Vitamin D and myocardial infarction
US10028991B2 (en) Composition, and method of using the composition, effective for minimizing the harmful effects associated with individuals suffering from alcohol intoxication
Amer et al. 5-Hydroxy-L-tryptophan suppresses food intake in food-deprived and stressed rats
US20090018151A1 (en) Topical Treatment of Peripheral diabetic complications
Glasauer Restless legs syndrome
US4435424A (en) Process for improving vigor and mood in normal human patients
KR20090033871A (ko) 비페프루녹스 및 ｌ-ｄｏｐａ를 포함하는 병용 제제
Tillerson et al. Book Review: Forced Limb-Use and Recovery following Brain Injury
MX2007006091A (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsionante.
JP2001510800A (ja) 注意欠損／活動亢進症の治療のためのアルカノイルカルニチン誘導体の使用
Hollister Clinical use of psychotherapeutic drugs II: antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs
JPH0465049B2 (enrdf_load_stackoverflow)
RU2096034C1 (ru) Фармацевтическая композиция, индуцирующая биосинтез глутатиона, активность глутатионтрансферазы и оказывающая антитоксическое, радиопротекторное и антигипоксическое действие, и способы лечения, профилактики и защиты с ее использованием
US4327112A (en) Process for increasing blood pressure
RU2169593C2 (ru) Способ лечения и профилактики сосудистых осложнений сахарного диабета
US20240075000A1 (en) Treatment of pathological fatigue with oxaloacetate
CA1320133C (en) Analgesic drug comprising l-tryptophan
EP0056401A1 (en) Process for improving vigor and mood in normal human patients
US4745130A (en) Composition for increasing blood pressure
Ekblom et al. L-Tryptophan supplementation does not affect postoperative pain intensity or consumption of analgesics